We reviewed all of the biotech mergers and acquisitions in 2021 and did a deep dive on the list of biotech M&A transactions focused on drug discovery. In this series, we provide a high level overview of:
- The drug discovery biotech acquisitions by total consideration in 2021
- The lead molecules in each acquisition and their structural representations where disclosed
- The mechanism of action, stage, and indication of each lead molecule
Dive into this series to learn more about the financial disclosures and the science behind the top large and small molecules that were acquired.
Navigate the 2021 M&A Series
- the top overall drug discovery M&A transactions by value (Part 1)
- the transactions with disclosed upfront payments (Part 2)
- the most valuable small molecule acquisitions (Part 3)
- the most valuable large molecule transactions (Part 4)
- the small molecules acquired in 2021 M&A: deep dive (Part 5)
- the large molecules acquired in 2021 M&As: deep dive (Part 6)
